Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

1.7K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.7K
Regulation of the Digestive System01:25

Regulation of the Digestive System

3.9K
Digestive activity regulation hinges on three primary components. Activation is prompted by a multitude of mechanical and chemical indicators, primarily detected by receptors within the stomach and intestines' walls. These receptors predominantly respond to factors such as mechanical stretching of the organ walls, changes in pH and osmolarity, and the presence of digesting materials and their by-products.
The effectors in this regulation system are glands and smooth muscles. Activation of...
3.9K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.5K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Major Organs of the Digestive System01:19

Major Organs of the Digestive System

12.6K
The digestive system is responsible for the ingestion of food, secretion of enzymes, mixing and digesting food, absorption of the nutrients and defecation. The human digestive system consists of two major parts: the gastrointestinal tract and the accessory digestive organs.
Gastrointestinal tract:
12.6K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.4K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

American Society of Clinical Oncology 2019.

P & T : a peer-reviewed journal for formulary management·2019
Same author

European Association for the Study of the Liver The International Liver Congress 2019.

P & T : a peer-reviewed journal for formulary management·2019
Same author

American College of Cardiology 68th Scientific Session and Exposition.

P & T : a peer-reviewed journal for formulary management·2019
Same author

American Society of Clinical Oncology Genitourinary Symposium and Integrative Healthcare Symposium.

P & T : a peer-reviewed journal for formulary management·2019
Same author

The 60th American Society of Hematology Annual Meeting & Exposition.

P & T : a peer-reviewed journal for formulary management·2019
Same author

American Heart Association 2018 Scientific Sessions.

P & T : a peer-reviewed journal for formulary management·2019

Related Experiment Video

Updated: Apr 6, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

69.4K

Digestive Disease Week.

Walter Alexander

    P & T : a Peer-Reviewed Journal for Formulary Management
    |July 18, 2015
    PubMed
    Summary

    This review covers pharmacological treatments for irritable bowel syndrome (IBS), pancreatitis, and Helicobacter pylori infection, highlighting key advancements in managing these gastrointestinal conditions.

    Area of Science:

    • Gastroenterology
    • Pharmacology
    • Internal Medicine

    Background:

    • Gastrointestinal disorders like irritable bowel syndrome (IBS), pancreatitis, and Helicobacter pylori infection pose significant clinical challenges.
    • Effective pharmacological management is crucial for improving patient outcomes and quality of life.

    Purpose of the Study:

    • To summarize key findings and advancements in the pharmacological treatment of IBS, pancreatitis, and H. pylori infection.
    • To provide an overview of recent developments presented in relevant scientific sessions.

    Main Methods:

    • Review of selected scientific sessions focusing on pharmacological interventions.
    • Synthesis of information on treatments for irritable bowel syndrome, pancreatitis, and H. pylori infection.

    More Related Videos

    DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
    09:04

    DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

    Published on: February 27, 2014

    49.4K
    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
    08:58

    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

    Published on: January 5, 2017

    13.0K

    Related Experiment Videos

    Last Updated: Apr 6, 2026

    Investigating Intestinal Inflammation in DSS-induced Model of IBD
    08:43

    Investigating Intestinal Inflammation in DSS-induced Model of IBD

    Published on: February 1, 2012

    69.4K
    DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
    09:04

    DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

    Published on: February 27, 2014

    49.4K
    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
    08:58

    Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

    Published on: January 5, 2017

    13.0K

    Main Results:

    • Key pharmacological strategies for irritable bowel syndrome were discussed across four sessions.
    • Significant sessions also addressed the pharmacological treatment of pancreatitis and Helicobacter pylori infection.

    Conclusions:

    • Pharmacological treatments remain a cornerstone in managing IBS, pancreatitis, and H. pylori infection.
    • Ongoing research and clinical discussions continue to refine therapeutic approaches for these conditions.